News

As fans of numerous science fiction series know (Matrix, Terminator, et al. we are looking at you), before too long our future robot overloads may be plotting our demise. In the meantime, however, they are proving to be incredibly helpful in areas like pharma manufacturing, attracting billions ...

Read more

Candesic Managing Partner Dr Leonid Shapiro and Principal Dr Joe Taylor explore the intriguing applications of cerebral organoids in the latest edition of PharmaTimes.These artificially grown minibrains have the potential to guide drug discovery, and lead to a powerful new generation of ...

Read more

What does the EU framework for AI innovation and regulation mean for the future of healthcare in Europe? Dr Leonid Shapiro, Managing Partner at Candesic, provides his views on the potential impact of the proposed regulation in Healthcare Business International. “This is a very fast-moving ...

Read more

Candesic Managing Partner Dr Leonid Shapiro and Principal Dr Joe Taylor discuss in an article in PharmaTimes Media Ltd how quantum computers can contribute to the development of new medicines – and potentially replace existing AI drug discovery platforms.

Read more

HealthInvestor features Dr Michelle Tempest, Senior Partner at Candesic, commenting on the government’s AI Life Sciences Accelerator Mission £100 million fund. The fund will provide a strong boost to UK life sciences and healthcare AI investment, and contribute to further healthcare ...

Read more

Government initiatives such as the £100m investment programme to accelerate use of AI in life sciences, and the AI Safety Summit to be held today and tomorrow, underscore the critical importance of driving and embracing AI's vast opportunities. Candesic's continued work in healthcare AI is ...

Read more

Dr Michelle Tempest looks at doctors attitudes towards IT and explore if the holy grail of connectivity and personalised health can finally come to fruition. With patient data potential to be 10-15 times more valuable to hackers than credit card data, the NHS is vulnerable to cyber ...

Read more

U.K.-based gynaecological health startup Daye, which is known for having invented the CBD tampon that is now used by over 60,000 women in the U.K., has completed a $11.5 million funding round. Candesic's Senior Partner Dr Michelle Tempest has also invested in this latest successful Series A ...

Read more

Candesic’s Joe Taylor takes on the hot topic of implantables. Many of you will know that Joe has the "implantable super power" of paying with his hand and here discusses how such technology is disrupting healthcare. Hat tip to Anna Luisa Schaffgotsch at Impli Limited.

Read more

Home health testing technology has come a long way in recent years and, driven in part by the pandemic, is set to be worth $8.15bn by 2030. Dr Michelle Tempest and Alina Trabattoni of Candesic examine the exponential growth and, given the right investment, the democratisation of healthcare it ...

Read more